Hunan Jiudian Pharmaceutical Co., Ltd. (SHE:300705)
China · Delayed Price · Currency is CNY 14.51
-0.32 (-2.16%)
At close: Mar 19, 2026
SHE:300705 Market Cap
SHE:300705 has a market cap or net worth of 7.17 billion as of March 19, 2026. Its market cap has decreased by -13.94% in one year.
Market Cap
7.17B
Enterprise Value
7.01B
Revenue
3.05B
Ranking
n/a
PE Ratio
15.83
Stock Price
14.51
Market Cap Chart
Since October 10, 2017, SHE:300705's market cap has increased from 1.75B to 7.17B, an increase of 309.25%. That is a compound annual growth rate of 18.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 19, 2026 | 7.17B | -3.12% |
| Dec 31, 2025 | 7.40B | -16.91% |
| Dec 31, 2024 | 8.91B | -22.34% |
| Dec 29, 2023 | 11.47B | 37.63% |
| Dec 30, 2022 | 8.33B | 1.05% |
| Dec 31, 2021 | 8.25B | 31.12% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 10, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiuzhitang | 7.79B |
| Shandong Wit Dyne Health | 7.78B |
| Zhejiang Tianyu Pharmaceutical | 7.78B |
| Northeast Pharmaceutical Group | 7.61B |
| HARBIN GLORIA PHARMACEUTICALS Co., LTD | 7.59B |
| Cisen Pharmaceutical | 7.50B |
| Frontier Biotechnologies | 7.46B |
| Sichuan Huiyu Pharmaceutical | 7.42B |